Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Vaccinations01:51

Vaccinations

52.8K
Overview
52.8K
Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
What is Genetic Engineering?00:49

What is Genetic Engineering?

80.7K
Overview
80.7K
Gene Therapy00:59

Gene Therapy

27.8K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SedNet: A physics-informed operator-learning framework for rapid sedimentation velocity analytical ultracentrifugation analysis.

International journal of pharmaceutics·2026
Same author

Rendering compact formation and trajectory tracking for cyber unmanned ground vehicles.

Fundamental research·2026
Same author

Drum Filling of Thin-Film Freeze-Dried Monoclonal Antibody Powder in UniDose Powder Nasal Spray System.

Pharmaceutical research·2025
Same author

Development of an inhalable dry powder of mycobacteriophage D29 using thin-film freeze-drying.

International journal of pharmaceutics·2025
Same author

IgM has a better relative distribution in inflammation sites and tumor tissues than IgG.

Journal of nanobiotechnology·2025
Same author

Heat transfer characteristics of sublimation from frozen thin films.

International journal of pharmaceutics·2025

Related Experiment Video

Updated: Mar 3, 2026

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.3K

Topical immunization using nanoengineered genetic vaccines.

Zhengrong Cui1, Russell J Mumper

  • 1Division of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|May 7, 2002
PubMed
Summary
This summary is machine-generated.

New nanoengineered genetic vaccines offer a cost-effective, topical method for enhanced immune responses. Mannan-coated nanoparticles significantly boost DNA vaccine efficacy, improving antigen-specific IgG titers and splenocyte proliferation.

More Related Videos

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.1K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Related Experiment Videos

Last Updated: Mar 3, 2026

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.3K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.1K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Area of Science:

  • Biotechnology
  • Immunology
  • Materials Science

Background:

  • DNA vaccines elicit humoral and cellular immunity but require effective delivery systems.
  • Current delivery methods like gene guns are not cost-effective.
  • Targeted delivery to dendritic cells (DCs) is crucial for potent vaccine responses.

Purpose of the Study:

  • To develop a cost-effective, nanoengineered genetic vaccine for simple topical application.
  • To enhance DC targeting and vaccine efficacy using mannan-coated nanoparticles.
  • To evaluate the immune response elicited by topical nanoengineered DNA vaccines.

Main Methods:

  • Plasmid DNA (pDNA) was coated onto cationic nanoparticles derived from O/W microemulsions.
  • Mannan, a DC ligand, was conjugated to nanoparticles, with or without endosomolytic agents (DOPE, cholesterol).
  • In vitro transfection and Concanavalin A (ConA) assays confirmed nanoparticle functionality and mannan presence. In vivo studies assessed humoral and cellular immune responses in mice.

Main Results:

  • Nanoengineered nanoparticles demonstrated successful in vitro transgene expression.
  • Mannan coating confirmed by ConA assay.
  • Topical application of pDNA-coated nanoparticles, particularly mannan-coated ones with DOPE, significantly enhanced antigen-specific IgG titers (16-fold) and splenocyte proliferation compared to naked pDNA.

Conclusions:

  • Nanoengineered cationic nanoparticles provide an effective platform for topical DNA vaccine delivery.
  • Mannan-coated nanoparticles enhance DC targeting and significantly boost humoral and cellular immune responses.
  • This strategy offers a promising, cost-effective alternative for vaccine development and delivery.